Medtech research spending set to slow in 2022

In 2020 the novel coronavirus prompted the largest medtech companies to boost their spending on R&D significantly, with the top 10 groups investing more than $15bn between them in bringing new technologies to market. And in 2021 the increase was even sharper, with this figure reaching $17.4bn.